1. Market Research
  2. > Healthcare Market Trends
  3. > Medical Device

Medical Device Industry Overview: Newest Market Reports & Studies

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
46 votes

Global Medical Device Market Research

As with most industries, the global medical device industry (a segment of the healthcare industry)  was not untouched by the economic crisis, though it has not deterred the industry’s overall growth. Smaller firms, unable to pick up the slack of product development costs previously covered by venture capital investors - now made more cautious by the economic slump - were obliged to curb their activity. Some other small firms, however, chose to merge with larger firms, thereby continuing technological advances without bearing the full burden of the cost. Domestic and international acquisitions and mergers allow a cross-border sharing of resources and knowledge, facilitating continued medical technology innovation despite the tough economic climate.

More evident challenges to the medical device sector include taxes on products in overseas markets as well as incongruous foreign regulatory controls and varying implementation of standards.

Medical Equipment Key Players & Regional Markets

The medical device industry covers a wide spectrum of products used in the treatment of patients, including cardiovascular devicesin-vitro diagnostic equipment, diagnostic devicesorthopedic devices, respiratory devicesdialysis devicesendoscopic devices, patient monitoring equipment, dental equipment,  ophthalmic device, and surgical equipment. In the US, medical devices are recognized as such in a book of public pharmacopeial standards, called the United States Pharmacopeia–National Formulary (USP– NF), and its supplements.

Top names in the industry include such medical technology leaders as Johnson & Johnson, Abbott Labs (ranked 69), Medtronic (ranked 158), Baxter (ranked 192), Boston Scientific, GE Healthcare Technologies, Becton Dickinson, St. Jude, Stryker Corporation and Beckman Coulter.

Regionally speaking, the US is the leading competitor, holding in excess of 40% of the world medical device market, reports Exvere private investment bank. The US is not only an important player in manufacturing and exporting medical device products but also creates about half of global market demand. It imports lower-technology medical device products, with a notable share coming from China, and tends to export higher-technology device products. While the US may see its stakes in the global market rise in the event of taxes being lowered, practices standardized and standards harmonized, it would also see more staunch foreign competition from countries that, even if they lag behind in innovation or expertise, could compete through the cheaper production of lower-technology medical devices.

Growing domestic production of lower-technology devices not just in China but also in India, Korea, Taiwan, and Brazil will help those nations become relative competitors to the US in the future; though the US is set to remain at the top of the higher-technology device market for some time.

While demand for medical devices in developed regions such as Japan, Canada, the EU and the US remains steady with annual growth rates of between 3% and 5%, developing regions are to prove lucrative for US exports, with demand in countries such as India and China showing more than twice the rate of developed countries. China’s sizeable population and healthy economic growth make it an increasingly promising target market. India equally shows potential as an export market for the US medical device sector due to its ever-more affluent population and strong accompanying private healthcare system.

At the moment Germany and the Netherlands are key competitors to the US for market share in higher-technology medical devices. However, some companies, such as Dutch firm Philips Electronics, are not completely independent players in so far as a good deal of their production is carried out in the US.

Medical Device Product Life Cycle

To enter the marketplace, medical devices must comply with pre-defined product life cycle parameters intended to maximize patient safety and ensure the highest quality standards. The product life cycle can be divided into three main phases. The first phase, or early product life cycle, consists of a product concept with its relevant market strategy and financing. The second phase, or the middle product life cycle, involves manufacturing and validation through clinical trials along with packaging and labeling. Lastly, the late product life-cycle phase consists of not only the market launch of the medical device but also market analysis that subsequently impacts on successive generations of the product.

Read more »

Customer Support

Talk to Sam

+852 5808 2421

120 Reports
Market Size, Demand, Company
93 Statistics
Market Size, Demand, Finance
890 Reports
Demand, Market Size, Supply
150 Statistics
Market Size, Demand, Finance
26 Reports
Market Size, Demand, Company Financials
19 Statistics
Market Size, Demand, Finance
74 Reports
Demand, Market Size, Company Financials
55 Statistics
Market Size, Demand, Finance
38 Reports
Supply, Demand, Market Size
16 Statistics
Market Size, Demand, Supply
52 Reports
Market Size, Trade, Demand
40 Statistics
Market Size, Demand, Market
28 Reports
Supply, Demand, Trade
29 Statistics
Market Size, Finance, Company Financials
11 Reports
Market Size, Supply, Demographic
7 Statistics
Market Size, Demographic, Supply
5 Reports
Market Size, Forecast, Company
5 Statistics
Market Size, Finance, Company Financials
18 Reports
Market Size, Company Financials, Demand
9 Statistics
Market Size, Finance, Company Financials

About 16000 reports

Purchase Reports From Reputable Market Research Publishers

A 33-Country Survey of the Automated Microbiology Market 2017-2022: Supplier Country Shares, Sales&Volume Forecast for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening&Immunodiagnostic Test

A 33-Country Survey of the Automated Microbiology Market 2017-2022: Supplier Country Shares, Sales&Volume Forecast for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening&Immunodiagnostic Test

  • $ 47500
  • Industry report
  • January 2018

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2018 World Coagulation Testing Analyzers and Reagents M ... $ 33500 March 2018

World Coagulation Testing Market 2017-2022: Supplier Co ... $ 33500 January 2018

A 33-Country Survey of the Coagulation Testing Market 2 ... $ 28500 January 2018

2018 Competing in the Global Clinical Chemistry and Imm ... $ 21800 April 2018

2019-2023 Global Hemostasis Diagnostic Analyzers and Re ... $ 21100 January 2019

2018 Global Hemostasis Diagnostics Market Shares, Segme ... $ 21100 September 2018

2018 Global Coagulation Market: US, Europe, Japan--Supp ... $ 21100 July 2018

2018 Global Coagulation Market Future Horizons and Grow ... $ 21100 June 2018

2018 Hemostasis Analyzers and Reagents Market: Supplier ... $ 21100 June 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on